Used as an intermediate in the synthesis of sulfonylurea derivatives, which exhibit potent carbonic anhydrase inhibitory activity. It plays a key role in developing therapeutic agents for glaucoma and other conditions involving fluid retention due to its ability to modulate ion transport in tissues. Its structural features support high selectivity toward certain carbonic anhydrase isoforms, making it valuable in designing targeted treatments with fewer side effects. Also investigated for potential applications in diuretic drugs and anti-tumor agents where pH regulation is critical.